Azra AI deal adds lung screening tools to incidental findings platform
Azra AI has acquired Thynk Health, a lung cancer screening and incidental findings management company. The combined platform will support imaging-driven care coordination from detection through diagnosis, treatment, and survivorship.
Azra AI has acquired Thynk Health to expand its enterprise platform for incidental findings and oncology workflow automation, according to the company. Financial terms of the deal were not disclosed.
The deal brings together Azra AI’s incidental findings and oncology workflow automation platform with Thynk Health’s lung cancer screening and incidental findings management technology.
Together, the platforms are deployed across hundreds of hospitals, including 5 of the top 10 healthcare systems in the U.S., Azra AI said. The combined systems process more than half a billion clinical reports and messages annually.
Thynk Health’s lung cancer screening and incidental findings tools will be integrated into Azra AI’s enterprise platform to support workflows across radiology, pathology, cardiology, and other service lines.
Health systems already using Thynk Health will gain access to Azra AI’s broader platform. Existing Azra AI customers will gain additional lung cancer screening and incidental findings capabilities, according to the announcement.
“Health systems are moving beyond fragmented tools,” said John Marshall, CEO of Azra AI. He will continue as CEO of the combined organization.
Daniel Weeks, formerly CEO of Thynk Health, will become chief operating officer at Azra AI. Both companies will continue supporting existing customer deployments during integration, with no disruption to current contracts or workflows, the company said.
Companies:Azra AI, Thynk Health
Sources
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Niowave breaks ground on $75M Ac-225 production facility
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
GE HealthCare, UW Medicine launch imaging research collaboration
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Radnostix reports 27% Q1 revenue decline
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Plus Therapeutics signs AI deal with Ephemeral
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm launches balloon-less EBUS bronchoscope
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST wins FDA clearance for Pro Diagnostic System
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.
QT Imaging prices $10M public offering
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.
PSMA PET guidance anchors EDAP-Telix HIFU prostate work
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.
UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.
Lumexa adds 4 imaging centers, including first UPMC JV site
Lumexa Imaging added 4 outpatient imaging centers across Pennsylvania, North Carolina, South Carolina, and Florida. The expansion includes acquired centers through joint ventures with UPMC and Advocate Health, plus 2 newly built locations.
PAI report finds 82% of U.S. physicians are now employed
A new PAI-Avalere report found that 82% of U.S. physicians are employed by hospitals, health systems, or corporate entities. Physician-owned settings now account for 18% of physicians and 36.1% of practices.